Abstract: There is provided a hybrid turf support for use with natural grass to form a stable hybrid turf system, the hybrid turf support comprising a knitted reticulated support; and a plurality of grass-like fibers extending upwardly from the knitted reticulated support, the grass-like fibers comprising groups of fibers extending upwardly at intervals.

Abstract: A turf surface (80) comprising: (a) a reinforcing root-permeable mat (10); (b) a removable root-permeable backing (60) located beneath the reinforcing root-permeable mat (10); (c) a layer of growth media (42) located on the reinforcing root-permeable mat (10); and (d) natural grass plants (30) having roots (32) extending downwardly through the layer of growth media (42) and the reinforcing root-permeable mat (10) and the removable root-permeable backing (60); wherein, in use, prior to being laid at a destination site, the removable root-permeable backing (60) is separated from the reinforcing root-permeable mat (10), so that any roots (34) which engage with and extend through the removable root-permeable backing (60) are substantially removed from the turf surface (80).

Abstract: A turf surface 80 comprising: (a) a reinforcing root-permeable mat 10; (b) a removable root-permeable backing 60 located beneath the reinforcing root-permeable mat 10; (c) a layer of growth media 42 located on the reinforcing root-permeable mat 10; and (d) natural grass plants 30 having roots 32 extending downwardly through the layer of growth media 42 and the reinforcing root-permeable mat 10 and the removable root-permeable backing 60; wherein, in use, prior to being laid at a destination site, the removable root-permeable backing 60 is separated from the reinforcing root-permeable mat 10, so that any roots 34 which engage with and extend through the removable root-permeable backing 60 are substantially removed from the turf surface 80.

Abstract: There is provided a hybrid turf support for use with natural grass to form a stable hybrid turf system, the hybrid turf support comprising a knitted reticulated support; and a plurality of grass-like fibers extending upwardly from the knitted reticulated support, the grass-like fibers comprising groups of fibers extending upwardly at intervals.

Abstract: A turf surface (80) comprising: (a) a reinforcing root-permeable mat (10); (b) a removable root-permeable backing (60) located beneath the reinforcing root-permeable mat (10); (c) a layer of growth media (42) located on the reinforcing root-permeable mat (10); and (d) natural grass plants (30) having roots (32) extending downwardly through the layer of growth media (42) and the reinforcing root-permeable mat (10) and the removable root-permeable backing (60); wherein, in use, prior to being laid at a destination site, the removable root-permeable backing (60) is separated from the reinforcing root-permeable mat (10), so that any roots (34) which engage with and extend through the removable root-permeable backing (60) are substantially removed from the turf surface (80).

Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.

Abstract: A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.

Abstract: A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.

Abstract: A pharmaceutical composition comprising Compound (1), characterised in that the composition comprises 2 to 12 mg of Compound (1) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.